Can a laser treat glaucoma without touching the eye?

NCT ID NCT06833060

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This pilot study tests a new laser device for treating open-angle glaucoma and ocular hypertension. The device uses a laser through the sclera (the white of the eye) to lower eye pressure, avoiding the need for a lens to touch the cornea. Researchers will check how safe the procedure is and whether it reduces eye pressure by at least 20% in the 30 days after treatment. The study involves 15 adults who are candidates for standard laser trabeculoplasty.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Transscleral Selective Laser Trabeculoplasty (TSLT) using a laser-OCT integrated system with eye tracking
What this could lead to
If successful, this could offer a safer, faster, and more comfortable laser treatment for glaucoma, reducing eye pressure without corneal contact.
What could go wrong
This is a small pilot study, so results may not apply broadly. The procedure could still cause side effects or fail to lower eye pressure enough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA, OPEN-ANGLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Central Adelaide Local Health Network - Royal Adelaide Hospital

    Adelaide, South Australia, 5000, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.